<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02584894</url>
  </required_header>
  <id_info>
    <org_study_id>PHAO 15- WEH / TETT- STIM</org_study_id>
    <nct_id>NCT02584894</nct_id>
  </id_info>
  <brief_title>Potentiation of Trauma Exposure in Post-traumatic Stress Disorder by Repeated Transcranial Magnetic Stimulation</brief_title>
  <acronym>TETT-STIM</acronym>
  <official_title>Potentiation of Trauma Exposure in Post-traumatic Stress Disorder by Repeated Transcranial Magnetic Stimulation : A Control Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess the efficacy in PTSD treatment of concomitant voluntary
      reactivation of personal traumatic memories with neuromodulation of the right dorsolateral
      prefrontal cortex using 10Hz rTMS, compared to 1Hz rTMS, during 2 weeks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-Traumatic Stress Disorder (PTSD) is characterized by intrusive and persistent memory of
      past result from an event causing or able to cause death, be a threat of death, a severe
      injury or constitute a threat for physical integrity. It is a frequent disorder in general
      population (8%). In France, The most frequent traumatic events causing PTSD are serious
      accidents, rape, physical assaults, violence, etc. PTSD treatment involves antidepressant and
      cognitive and behavioural psychotherapy, which encourage exposure to elements that remind the
      trauma (memories, circumstances), with the objective of reducing the fear associated with the
      traumatic memories. Innovative therapeutic strategies aim to improve the psychotherapeutic
      effect with enhancement drugs or using neuromodulatory techniques, such as repeated
      transcranial magnetic stimulation (rTMS).

      The aim of this study is to assess the efficacy in PTSD treatment of concomitant voluntary
      reactivation of personal traumatic memories with neuromodulation of the right dorsolateral
      prefrontal cortex using 10Hz rTMS, compared to 1Hz rTMS, during 2 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline Score at Clinician administered PTSD scale</measure>
    <time_frame>inclusion ; 1 months; 3 months</time_frame>
    <description>Score at Clinician administered PTSD scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Score at PTSD Checklist (self-assessment)</measure>
    <time_frame>inclusion ; 1 month; 3 months</time_frame>
    <description>Score at PTSD Checklist (self-assessment) for severity of PTSD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Score at PTSD Checklist (self-assessment) for different dimensions of PTSD</measure>
    <time_frame>inclusion ; 1 month; 3 months</time_frame>
    <description>Score at PTSD Checklist (self-assessment) for severity of different dimensions of PTSD</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Score at anxiety and depression item on Hamilton Anxiety Rating Scale (HAM-A)</measure>
    <time_frame>inclusion ; 1 month; 3 months</time_frame>
    <description>Score at anxiety and depression item on Hamilton Anxiety Rating Scale (HAM-A)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline Score at depression item on Hamilton Anxiety Rating Scale (HAM-A)</measure>
    <time_frame>inclusion ; 1 month; 3 months</time_frame>
    <description>Score at depression item on Hamilton Depression Rating Scale (HAM-D)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline heart rate</measure>
    <time_frame>inclusion ; 1day ; 1 month, 3 months</time_frame>
    <description>heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline electrodermal conductance</measure>
    <time_frame>inclusion ; 1day ; 1 month, 3 months</time_frame>
    <description>electrodermal conductance measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse effect</measure>
    <time_frame>inclusion ; 1day ; 1 month, 3 months</time_frame>
    <description>Adverse effect</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Stress Disorders, Post-Traumatic</condition>
  <arm_group>
    <arm_group_label>rTMS 1Hz</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects have 8 session of trauma exposure with repeated transcranial magnetic stimulation (rTMS) at 1Hz on dorsolateral prefrontal cortex (1Hz rTMS is describe in the literature to have no effect on the dorsolateral prefrontal cortex). psychoneurological assessment. Electrodermal conductance measure With conductivity meter . Heart rate measure With electrocardiogram</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rTMS 10Hz</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects have 8 session of trauma exposure with repeated transcranial magnetic stimulation (rTMS) at 10Hz on dorsolateral prefrontal cortex (10Hz rTMS is describe in the literature to have effect on the dorsolateral prefrontal cortex). psychoneurological assessment. Electrodermal conductance measure With conductivity meter. Heart rate measure with electrocardiogram</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rTMS 1Hz</intervention_name>
    <description>trauma exposure + repeated transcranial magnetic stimulation at 1Hz</description>
    <arm_group_label>rTMS 1Hz</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rTMS 10Hz</intervention_name>
    <description>trauma exposure + repeated transcranial magnetic stimulation at 10Hz</description>
    <arm_group_label>rTMS 10Hz</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>psychoneurological assessment</intervention_name>
    <description>psychoneurological assessment</description>
    <arm_group_label>rTMS 1Hz</arm_group_label>
    <arm_group_label>rTMS 10Hz</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>conductivity meter</intervention_name>
    <description>electrodermal conductance measure</description>
    <arm_group_label>rTMS 1Hz</arm_group_label>
    <arm_group_label>rTMS 10Hz</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>electrocardiogram</intervention_name>
    <description>heart rate measure</description>
    <arm_group_label>rTMS 1Hz</arm_group_label>
    <arm_group_label>rTMS 10Hz</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  PCLS score &gt;40

          -  Able to give his written informed consent

          -  Not participating another study

          -  Affiliation to a social security system

          -  Having a PTSD for 3 months

          -  No treatment modification for 4 weeks (Psychotropic treatment or structured
             psychotherapy)

        Exclusion Criteria:

          -  Partially deaf with equipment

          -  people with identified neurological disease

          -  people with addiction to psychoactive substance

          -  people who can't conform to tests

          -  people having a contraindication for rTMS (cochlear implant )

          -  people suffering from chronicle or acute delusional disorder

          -  any circumstances making the people unable to understood nature, aim or consequences
             of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wissam EL-HAGE, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU Tours</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wissam EL-HAGE, PhD</last_name>
    <phone>02 34 37 89 47</phone>
    <phone_ext>+33</phone_ext>
    <email>W.ELHAGE@chu-tours.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>julien BOUCHERON, master</last_name>
    <phone>02 18 37 05 97</phone>
    <phone_ext>+33</phone_ext>
    <email>j.boucheron@chu-tours.fr</email>
  </overall_contact_backup>
  <reference>
    <citation>Quidé Y, Witteveen AB, El-Hage W, Veltman DJ, Olff M. Differences between effects of psychological versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: a systematic review. Neurosci Biobehav Rev. 2012 Jan;36(1):626-44. doi: 10.1016/j.neubiorev.2011.09.004. Epub 2011 Sep 24. Review.</citation>
    <PMID>21963442</PMID>
  </reference>
  <reference>
    <citation>Tapia G, Clarys D, Bugaiska A, El-Hage W. Recollection of negative information in posttraumatic stress disorder. J Trauma Stress. 2012 Feb;25(1):120-3. doi: 10.1002/jts.21659. Epub 2012 Jan 25.</citation>
    <PMID>22278745</PMID>
  </reference>
  <reference>
    <citation>Landré L, Destrieux C, Andersson F, Barantin L, Quidé Y, Tapia G, Jaafari N, Clarys D, Gaillard P, Isingrini M, El-Hage W. Working memory processing of traumatic material in women with posttraumatic stress disorder. J Psychiatry Neurosci. 2012 Feb;37(2):87-94. doi: 10.1503/jpn.100167.</citation>
    <PMID>21971161</PMID>
  </reference>
  <reference>
    <citation>Landré L, Destrieux C, Baudry M, Barantin L, Cottier JP, Martineau J, Hommet C, Isingrini M, Belzung C, Gaillard P, Camus V, El Hage W. Preserved subcortical volumes and cortical thickness in women with sexual abuse-related PTSD. Psychiatry Res. 2010 Sep 30;183(3):181-6. doi: 10.1016/j.pscychresns.2010.01.015. Epub 2010 Aug 4.</citation>
    <PMID>20688488</PMID>
  </reference>
  <reference>
    <citation>Jaafari N, Rachid F, Rotge JY, Polosan M, El-Hage W, Belin D, Vibert N, Pelissolo A. Safety and efficacy of repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder: a review. World J Biol Psychiatry. 2012 Mar;13(3):164-77. doi: 10.3109/15622975.2011.575177. Epub 2011 May 30. Review.</citation>
    <PMID>21623668</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 14, 2015</study_first_submitted>
  <study_first_submitted_qc>October 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 23, 2015</study_first_posted>
  <last_update_submitted>October 22, 2015</last_update_submitted>
  <last_update_submitted_qc>October 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stress Disorders, Post-Traumatic</keyword>
  <keyword>trauma exposure</keyword>
  <keyword>Repeated transcranial magnetic stimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

